Saltar al contenido
Merck
  • GATA4 represses an ileal program of gene expression in the proximal small intestine by inhibiting the acetylation of histone H3, lysine 27.

GATA4 represses an ileal program of gene expression in the proximal small intestine by inhibiting the acetylation of histone H3, lysine 27.

Biochimica et biophysica acta (2014-06-01)
B E Aronson, S Rabello Aronson, R P Berkhout, S F Chavoushi, A He, W T Pu, M P Verzi, S D Krasinski
RESUMEN

GATA4 is expressed in the proximal 85% of small intestine where it promotes a proximal intestinal ('jejunal') identity while repressing a distal intestinal ('ileal') identity, but its molecular mechanisms are unclear. Here, we tested the hypothesis that GATA4 promotes a jejunal versus ileal identity in mouse intestine by directly activating and repressing specific subsets of absorptive enterocyte genes by modulating the acetylation of histone H3, lysine 27 (H3K27), a mark of active chromatin, at sites of GATA4 occupancy. Global analysis of mouse jejunal epithelium showed a statistically significant association of GATA4 occupancy with GATA4-regulated genes. Occupancy was equally distributed between down- and up-regulated targets, and occupancy sites showed a dichotomy of unique motif over-representation at down- versus up-regulated genes. H3K27ac enrichment at GATA4-binding loci that mapped to down-regulated genes (activation targets) was elevated, changed little upon conditional Gata4 deletion, and was similar to control ileum, whereas H3K27ac enrichment at GATA4-binding loci that mapped to up-regulated genes (repression targets) was depleted, increased upon conditional Gata4 deletion, and approached H3K27ac enrichment in wild-type control ileum. These data support the hypothesis that GATA4 both activates and represses intestinal genes, and show that GATA4 represses an ileal program of gene expression in the proximal small intestine by inhibiting the acetylation of H3K27.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Glicerol, ACS reagent, ≥99.5%
Sigma-Aldrich
Glicerol, for molecular biology, ≥99.0%
Sigma-Aldrich
Tamoxifeno, ≥99%
Sigma-Aldrich
Glicerol, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
Formaldehído solution, for molecular biology, 36.5-38% in H2O
SAFC
Formaldehído solution, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Sigma-Aldrich
Anti-β-actina monoclonal antibody produced in mouse, clone AC-15, ascites fluid
Sigma-Aldrich
Formaldehído solution, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
Sigma-Aldrich
Glicerol, ≥99.5%
Sigma-Aldrich
Glicerol solution, 83.5-89.5% (T)
Sigma-Aldrich
Glicerol, puriss., anhydrous, 99.0-101.0% (alkalimetric)
Sigma-Aldrich
Glicerol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
Glicerol, BioUltra, for molecular biology, anhydrous, ≥99.5% (GC)
Sigma-Aldrich
Formaldehído solution, for molecular biology, BioReagent, ≥36.0% in H2O (T)
USP
Glicerol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Glicerol, FCC, FG
Sigma-Aldrich
Glicerol, puriss. p.a., ACS reagent, anhydrous, dist., ≥99.5% (GC)
Supelco
Formaldehído solution, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Supelco
Glicerol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Formaldehído solution, meets analytical specification of USP, ≥34.5 wt. %
Sigma-Aldrich
Glicerol, BioXtra, ≥99% (GC)
Sigma-Aldrich
Glicerol solution, puriss., meets analytical specification of Ph. Eur., BP, 84-88%
Sigma-Aldrich
Glicerol, meets USP testing specifications
Sigma-Aldrich
Formaldehído solution, tested according to Ph. Eur.
Supelco
Tamoxifeno, analytical standard
Supelco
Glicerol, analytical standard
Sigma-Aldrich
Glicerol, tested according to Ph. Eur., anhydrous
Sigma-Aldrich
Formaldehyde-12C solution, 20% in H2O, 99.9 atom % 12C